Inherited cancer predisposition syndromes in Greece

Loading...
Thumbnail Image

Date

Authors

Apessos, A.
Papadopoulou, E.
Belogianni, I.
Baratsis, S.
Triantafillidis, J. K.
Kosmidis, P.
Karydas, E.
Briasoulis, E.
Pisiotis, C.
Papazisis, K.

Journal Title

Journal ISSN

Volume Title

Publisher

Abstract

Type of the conference item

Journal type

peer-reviewed

Educational material type

Conference Name

Journal name

Anticancer Res

Book name

Book series

Book edition

Alternative title / Subtitle

Description

Hereditary cancer syndromes comprise approximately 5-10% of diagnosed carcinomas. They are caused by mutations in specific genes. Carriers of mutations in these genes are at an increased risk of developing cancer at a young age. When there is a suspicion of a hereditary cancer predisposition syndrome a detailed family tree of the patient requesting screening is constructed. DNA is isolated from all available members of the family. Mutation detection is carried out on DNA from an affected family member. If a mutation is found the remaining family is screened. The genetic basis of a large number of inherited cancer predisposition syndromes is known. In this paper the focus is on mutations in genes responsible for colorectal cancer, meaning adenomatous polyposis coli (APC), which is involved in familial adenomatous polyposis and homo sapiens mutL homolog 1 (hMLH1) and homo sapiens mutS homolog 2 (hMSH2), involved in hereditary non-polyposis colorectal cancer. In addition, the genes responsible for inherited breast and/or ovarian cancer, breast cancer genes 1 and 2 (BRCA1 and BRCA2), and the rearranged during transfection protooncogene RET which is responsible for multiple endocrine neoplasia type 2 are discussed. In all cases emphasis is given to the data available on the Greek population.

Description

Keywords

Adaptor Proteins, Signal Transducing/genetics, Adenomatous Polyposis Coli/genetics, Breast Neoplasms/*genetics, Colorectal Neoplasms/*genetics, Colorectal Neoplasms, Hereditary Nonpolyposis/genetics, Genes, BRCA1, Genes, BRCA2, Genetic Predisposition to Disease, Greece, Humans, MutS Homolog 2 Protein/genetics, Mutation, Nuclear Proteins/genetics, Pedigree

Subject classification

Citation

Link

http://www.ncbi.nlm.nih.gov/pubmed/18505076

Language

en

Publishing department/division

Advisor name

Examining committee

General Description / Additional Comments

Institution and School/Department of submitter

Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής

Table of contents

Sponsor

Bibliographic citation

Name(s) of contributor(s)

Number of Pages

Course details

Endorsement

Review

Supplemented By

Referenced By